Nano-X Imaging Ltd.
https://www.nanox.vision/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nano-X Imaging Ltd.
Dealmaking Quarterly Statistics, Q3 2021
In the third quarter of 2021, medical device company M&A values reached $7.1bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $6.7bn.
Financing: 2020 Ends On A High Note For Medtech
During Q4, device company fundraising totaled $4.2bn; while in vitro diagnostic firms and research tools players raised $6.1bn.
Medical Imaging Disruptor Nano-X Pushes On With Launch Plans In Face Of Shareholder Lawsuit
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
Company Information
- Industry
- Services
-
Medical Devices
-
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- X-ray
-
Diagnostic Imaging Equipment & Supplies
-
Digital Health
- Artificial Intelligence
- Other Names / Subsidiaries
-
- Nanox.A
- Zebra Medical Vision
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice